News
We assign a narrow moat rating for Alibaba Health due to its network effect from the number of healthcare merchants, pharmacies, and online doctors on its platform, and intangible assets that come ...
A Chinese online shopping platform has sparked controversy in South Korea for selling merchandise featuring a portrait of ...
1d
Statista on MSNChinese Trade Surplus with Neighbors GrowsData from the General Administration of Customs China shows that while the Chinese trade surplus with ASEAN countries was ...
Alibaba’s CMR and Cloud growth rebound, AI tailwinds, and easing U.S.-China tensions signal upside. Read why BABA stock is a ...
Digital Media and Entertainment Group (2.3% of total revenues): Revenues were RMB 5.6 billion ($765 million), up 12% from the ...
Alibaba stock sank after its earnings results disappointed investors. Alibaba (NYSE: BABA) stock has had a good start to 2025 ...
Detailed price information for Alibaba Group Holding ADR (BABA-N) from The Globe and Mail including charting and trades.
Although these changes are primarily applied to improve companies’ performance in stock markets, they could significantly ...
Analyst maintained Buy rating, lowered price target for Alibaba. Q4 revenue missed estimates due to divestitures, but strong ...
BABA has an average analyst rating of buy and is -23.35% away from its mean target price of $163.2 per share Its trailing earnings per share (EPS) is $6.91 Alibaba has a trailing 12 month Price to ...
We estimate that the rising adoption of Quanzhantui should help Alibaba enhance monetization until fiscal 2026.
Good day, ladies and gentlemen. Thank you for standing by. Welcome to Alibaba Group’s March Quarter 2025 and Full Fiscal Year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results